Vieregge P
Department of Neurology, Medical University, Lübeck, Federal Republic of Germany.
J Neural Transm Park Dis Dement Sect. 1994;8(1-2):1-37. doi: 10.1007/BF02250916.
Overshadowed by a vigorous search for an environmentally-derived toxin that would be possibly relevant for the pathogenesis of idiopathic Parkinson's disease (PD), genetic factors have largely been neglected for this condition during the last two decades. Recent descriptions of kindreds over three or more generations with several family members affected have renewed the interest in genetics of PD. Concurring with this, diagnostic concepts and pathologic criteria for PD and for idiopathic Lewy-body (LB) disease have been reevaluated such that LB-proven parkinsonism is sufficiently differentiated from familial parkinsonism without LB pathology. Surveys on genetic epidemiology in PD have confirmed the 19th century's notion that 10 to 15% of PD index cases report a further family member with PD. These figures were, however, substantiated on a statistical basis only in single surveys when comparisons were made with the numbers of PD relatives in control index cases. Twin studies did not reveal a higher rate of concordance within monozygotic pairs than in dizygotic pairs. Tests of striatal 18-F-Dopa uptake in clinically unaffected mono- and dizygotic co-twins did not alter the ratio between the concordance rates. Though not excluded by the twin studies, multifactorial (or polygenic) inheritance as well as mitochondrial inheritance are at present less likely to cover most of the inheritance pattern in familial LB parkinsonism. Instead, autosomal dominant inheritance with reduced penetrance is the most probable inheritance pattern for most of the reported pedigrees. Molecular genetic investigations have to consider the biochemical basis of the age- and region-specific pathology of PD. The first analyses of linkage and allelic associations gave inconclusive results in sporadic and familial PD. The hunt for metabolic factors that link geno- and phenotype expression in PD will continue.
在对可能与特发性帕金森病(PD)发病机制相关的环境毒素进行积极探索的阴影下,在过去二十年中,遗传因素在很大程度上被忽视了。最近对三代或三代以上有多个家庭成员患病的家族的描述,重新唤起了人们对PD遗传学的兴趣。与此同时,对PD和特发性路易体(LB)病的诊断概念和病理标准进行了重新评估,以便将经LB证实的帕金森症与无LB病理的家族性帕金森症充分区分开来。对PD遗传流行病学的调查证实了19世纪的观点,即10%至15%的PD索引病例报告有另一位家庭成员患有PD。然而,只有在单项调查中与对照索引病例中的PD亲属数量进行比较时,这些数字才在统计基础上得到证实。双胞胎研究并未发现同卵双胞胎对之间的一致性率高于异卵双胞胎对。对临床未受影响的同卵和异卵双胞胎进行纹状体18-F-多巴摄取测试,并未改变一致性率之间的比例。虽然双胞胎研究并未排除多因素(或多基因)遗传以及线粒体遗传,但目前它们不太可能涵盖家族性LB帕金森症的大多数遗传模式。相反,外显率降低的常染色体显性遗传是大多数已报道家系最可能的遗传模式。分子遗传学研究必须考虑PD年龄和区域特异性病理的生化基础。对散发性和家族性PD进行的首次连锁分析和等位基因关联分析得出了不确定的结果。寻找将PD中的基因和表型表达联系起来的代谢因素的工作将继续进行。